The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates
Main Authors: | Rachel J. Church, Paul B. Watkins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12900 |
Similar Items
-
Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults
by: K. Chris Min, et al.
Published: (2021-03-01) -
THROMBOCYTOPENIA AND ELEVATED ALANINE AMINOTRANSFERASE LEVELS IN MALARIA PATIENTS
by: Sayed Tanveer Abbas Gilani, et al.
Published: (2021-01-01) -
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
by: Johann von Felden, et al.
Published: (2020-09-01) -
Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males
by: Wendy Ankrom, et al.
Published: (2020-05-01) -
Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase
by: Janaína Luz Narciso-Schiavon, et al.